摘要:
In accordance with the invention, there is provided a method for preventing or treating a disease associated with abnormal cell proliferation, or for modulating or controlling apoptosis, wherein the method comprises administering to a patient in need of such treatment an effective amount of at least one human immunodeficiency virus (HIV) protease inhibiting compound, in particular ritonavir, saquinavir, or one of their pharmaceutically acceptable salts, in combination with a pharmaceutically acceptable vehicle. The method will thus be especially useful in treating diseases resulting from abnormal cell proliferation such as cancer.
摘要:
The invention provides a method for treating a cognitive dysfunction comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thienonull2,3-bnullnull1,5nullbenzodiazepine.
摘要:
A fluorine-containing cyclic ester is represented by the formula 1: 1 wherein each R1 independently represents nullH or nullF, wherein R2 is one selected from the group consisting of nullH, nullF, nullCF3, nullOH, nullCOOH and nullCOOR4, where R4 is an alkyl group having a carbon atom number of 1-15, and wherein R3 is a substituent selected from the group consisting of nullF, nullCF3, and nullR5C(CF3)2OR6, where R5 is one selected from the group consisting of CH2, C2H4, and OCH2, and R6 is H or an acid-labile protecting group.
摘要:
Compounds having heterocyclic groups containing two nitrogen atoms are disclosed. The compounds are useful for treating multidrug resistance. The compounds can be formulated in compositions with a carrier and, optionally, a therapeutic agent. One suitable compound has the formula: 1
摘要:
The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and methods of using benzodiazepine derivatives as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, and hyperproliferation, and the like.
摘要:
The present invention is directed towards a pharmaceutical composition useful for the treatment of allergic rhinitis, asthma and related disorders. In one embodiment, the composition comprises, in combination, a therapeutically effective amount of at least one neurokinin antagonist, and a therapeutically effective amount of at least one 5-lipoxygenase inhibitor.
摘要:
The present invention relates to a class of compounds having affinity for certain cancer cells, e.g. lung carcinomas, colon carcinomas, renal carcinomas, prostate carcinomas, breast carcinomas, malignant melanomas, gliomas, neuroblastomas and pheochromocytomas. The compounds of the present invention can also bind with high specificity to cell surface sigma receptors and can therefore be used for diagnostic imaging of any tissue having an abundance of cells with sigma receptors. The present invention provides such compounds as agents for diagnostic imaging and for detecting and treating tumors containing the cancer cells described above.